Koers Panacos Pharmaceuticals, Inc. Other OTC
Aandelen
PANC
US69811Q1067
Biotechnologie & Medisch Onderzoek
Omzet 2006 | 284K 261K | Omzet 2007 | 180K 165K | Marktkapitalisatie | 42,29 mln. 38,87 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2006 | -38 mln. -34,93 mln. | Nettowinst (verlies) 2007 | -37 mln. -34,01 mln. | EV/omzet 2006 | 504 x |
Nettoliquiditeiten 2006 | 60,4 mln. 55,52 mln. | Nettoliquiditeiten 2007 | 32,58 mln. 29,95 mln. | EV/omzet 2007 | 53,9 x |
K/w-verhouding 2006 |
-5,32
x | K/w-verhouding 2007 |
-1,12
x | Werknemers | - |
Dividendrendement 2006 * |
-
| Dividendrendement 2007 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John R. Barr
CEO | Chief Executive Officer | 67 | - |
Thomas Higgins
DFI | Director of Finance/CFO | 72 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,41% | 111 mld. | |
+11,25% | 106 mld. | |
-12,66% | 22,24 mld. | |
+0,44% | 21,25 mld. | |
-4,18% | 18,97 mld. | |
-37,85% | 18,52 mld. | |
-8,77% | 16,81 mld. | |
+37,47% | 12,54 mld. | |
-24,05% | 8,09 mld. |